SUN PHARMACEUTICAL INDUSTRIES LTD. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,532 INR | +0.03% |
|
+1.68% | +21.63% |
ETFs positioned on Sun Pharmaceutical Industries Ltd.
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.01% | 54 M€ | +1.01% | - | |
| 0.01% | 8 M€ | +1.17% | - | |
| 0.00% | 7 M€ | +0.11% | - |
Sun Pharmaceutical Industries Ltd. is one of the Indian leaders of pharmaceutical groups. Net sales break down by family of products as follows:
- generic and OTC medicines (94%): for cardiologic, psychiatric, neurological, gastroenterological, diabetic and respiratory diseases treatment;
- other (6%) : primarily active pharmaceutical ingredients.
At the end of March 2021, the group had 44 production plants worldwide.
Net sales are distributed geographically as follows: India (33%), the United States (31.3%), other (35.7%).
Sector
Pharmaceuticals
Calendar
2024-05-21
- Q4 2024 Earnings Release
Trading Rating
Investor Rating
ESG Refinitiv
B-
Sell
Buy
Mean consensus
BUY
Number of Analysts
36
Last Close Price
1,532
INR
Average target price
1,575
INR
Spread / Average Target
+2.82%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +21.63% | 44.11B | |
| +23.03% | 22.71B | |
| +18.22% | 15.15B | |
| +12.66% | 13.56B | |
| +60.18% | 12.7B | |
| -10.02% | 6.84B | |
| -0.05% | 6.79B | |
| -8.87% | 5.73B | |
| +12.92% | 5.63B | |
| +6.11% | 4.77B |
- Stock Market
- Equities
- SUNPHARMA Stock
- Funds and ETFs Sun Pharmaceutical Industries Ltd.
